XML 134 R68.htm IDEA: XBRL DOCUMENT v3.23.3
Financial instruments - disclosures (Tables)
12 Months Ended
Oct. 31, 2023
Text Block [Abstract]  
Schedule of Balance Sheet Exposure Credit Risk under Different Basel Approaches
$ millions, as at October 31   IRB
approach
 (1)
    Standardized
approach
    Other
credit risk
 
(2)
    Total
subject to
credit risk
    Not
subject to
credit risk
     Total
consolidated
balance sheet
 
2023
 
Cash and deposits with banks
 
$
39,692
 
 
$
13,798
 
 
$
2,228
 
 
$
55,718
 
 
$
 
  
$
55,718
 
 
Securities
 
 
129,320
 
 
 
16,070
 
 
 
 
 
 
145,390
 
 
 
65,958
 
  
 
211,348
 
 
Cash collateral on securities borrowed
 
 
14,571
 
 
 
80
 
 
 
 
 
 
14,651
 
 
 
 
  
 
14,651
 
 
Securities purchased under resale agreements
 
 
80,184
 
 
 
 
 
 
 
 
 
80,184
 
 
 
 
  
 
80,184
 
 
Loans
 
 
467,047
 
 
 
60,868
 
 
 
1,620
 
 
 
529,535
 
 
 
3,704
 
  
 
533,239
 
 
Allowance for credit losses
 
 
(3,078
 
 
(824
 
 
 
 
 
(3,902
 
 
 
  
 
(3,902
 
Derivative instruments
 
 
33,243
 
 
 
 
 
 
 
 
 
33,243
 
 
 
 
  
 
33,243
 
 
Customers’ liability under acceptances
 
 
10,574
 
 
 
358
 
 
 
(116
 
 
10,816
 
 
 
 
  
 
10,816
 
 
 
Other assets
 
 
20,661
 
 
 
465
 
 
 
7,233
 
 
 
28,359
 
 
 
12,063
 
  
 
40,422
 
 
 
Total credit exposures
 
$
792,214
 
 
$
90,815
 
 
$
10,965
 
 
$
893,994
 
 
$
81,725
 
  
$
975,719
 
2022
 
Total credit exposures
  $     781,668     $     86,056     $     11,955     $     879,679     $     63,918      $     943,597  
 
(1)
Effective in the second quarter of 2023, the IRB approach includes both the Advanced IRB (AIRB) approach and the Foundation IRB (FIRB) approach.
(2)
Includes credit risk exposures arising from other assets that are subject to the credit risk framework but are not included in the standardized or IRB frameworks, including other balance sheet assets which are risk-weighted at 100%, significant investments in the capital of
non-financial
institutions, and amounts below the thresholds for capital deduction that are risk-weighted at 250%.